NICE Throws P&G/Sanofi A Bone With Osteoporosis Guidance
This article was originally published in The Pink Sheet Daily
Executive Summary
Reversing an earlier appraisal, UK agency recommends Actonel as alternative to generic Fosamax in prevention of fracture in postmenopausal osteoporosis.
You may also be interested in...
Bisphosphonate Marketers Push Dosing Advantages After Feb. 6 Fosamax Patent Expiry
Branded osteoporosis drug makers gird for a hit from launch of a low-cost version of Merck’s market leading alendronate.
Hologic's Adiana Permanent Birth Control Device Takes On Conceptus' Essure
Adiana uses a polymer matrix insert to block the fallopian tubes instead of a metal coil, offering a benefit over Essure, which carries a perforation risk on implantation, Hologic exec says.
MADIT-CRT Data Support Expanded Cardiac Resynchronization Market
The results show that cardiac resynchronization defibrillators "slow the progression of heart failure in asymptomatic and mildly symptomatic patients," potentially expanding the market by $600 million.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: